This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neyts, J.
Right arrow Articles by De Clercq, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neyts, J.
Right arrow Articles by De Clercq, E.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., 12 1997, 2754-2756, Vol 41, No. 12
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Antiviral drug susceptibility of human herpesvirus 8

J Neyts and E De Clercq
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium. Johan.Neyts@rega.kuleuven.ac.be

We studied the susceptibility of human herpesvirus 8 (HHV-8) to a number of antiherpesvirus agents. The acyclic nucleoside phosphonate (ANP) analogs cidofovir and HPMPA [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] effected potent inhibition of HHV-8 DNA synthesis, with 50% effective concentrations (EC50) of 6.3 and 0.6 microM, respectively. Adefovir, an ANP with both antiretrovirus and antiherpesvirus activity, blocked HHV-8 DNA replication at a fourfold- lower concentration than did foscarnet (EC50 of 39 and 177 microM, respectively). The most potent inhibitory effect was obtained with the N-7-substituted nucleoside analog S2242 (EC50, 0.11 microM). The nucleoside analogs acyclovir, penciclovir, H2G (R)-9-[4-hydroxy-2- (hydroxymethyl) butyl]guanine, and brivudine had weak to moderate effects (EC50 of > or =75, 43, 42, and 24 microM, respectively, and EC90 of > or =75 microM), whereas ganciclovir elicited pronounced anti- HHV-8 activity (EC50, 8.9 microM).


This article has been cited by other articles:

  • Davis, D. A., Singer, K. E., Reynolds, I. P., Haque, M., Yarchoan, R. (2007). Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells. Cancer Res. 67: 7003-7010 [Abstract] [Full Text]  
  • Williams-Aziz, S. L., Hartline, C. B., Harden, E. A., Daily, S. L., Prichard, M. N., Kushner, N. L., Beadle, J. R., Wan, W. B., Hostetler, K. Y., Kern, E. R. (2005). Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro. Antimicrob. Agents Chemother. 49: 3724-3733 [Abstract] [Full Text]  
  • Staudt, M. R., Kanan, Y., Jeong, J. H., Papin, J. F., Hines-Boykin, R., Dittmer, D. P. (2004). The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo. Cancer Res. 64: 4790-4799 [Abstract] [Full Text]  
  • De Clercq, E. (2003). Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections. Clin. Microbiol. Rev. 16: 569-596 [Abstract] [Full Text]  
  • Sergerie, Y., Boivin, G. (2003). Evaluation of Susceptibility of Human Herpesvirus 8 to Antiviral Drugs by Quantitative Real-Time PCR. J. Clin. Microbiol. 41: 3897-3900 [Abstract] [Full Text]  
  • Gaspar, G., De Clercq, E., Neyts, J. (2002). Human Herpesvirus 8 Gene Encodes a Functional Thymidylate Synthase. J. Virol. 76: 10530-10532 [Abstract] [Full Text]  
  • Curreli, F., Cerimele, F., Muralidhar, S., Rosenthal, L. J., Cesarman, E., Friedman-Kien, A. E., Flore, O. (2002). Transcriptional Downregulation of ORF50/Rta by Methotrexate Inhibits the Switch of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 from Latency to Lytic Replication. J. Virol. 76: 5208-5219 [Abstract] [Full Text]  
  • Liekens, S., Neyts, J., De Clercq, E., Verbeken, E., Ribatti, D., Presta, M. (2001). Inhibition of Fibroblast Growth Factor-2-induced Vascular Tumor Formation by the Acyclic Nucleoside Phosphonate Cidofovir. Cancer Res. 61: 5057-5064 [Abstract] [Full Text]  
  • Antman, K., Chang, Y. (2000). Kaposi's Sarcoma. NEJM 342: 1027-1038 [Full Text]  
  • Gustafson, E. A., Schinazi, R. F., Fingeroth, J. D. (2000). Human Herpesvirus 8 Open Reading Frame 21 Is a Thymidine and Thymidylate Kinase of Narrow Substrate Specificity That Efficiently Phosphorylates Zidovudine but Not Ganciclovir. J. Virol. 74: 684-692 [Abstract] [Full Text]  
  • Zoeteweij, J. P., Eyes, S. T., Orenstein, J. M., Kawamura, T., Wu, L., Chandran, B., Forghani, B., Blauvelt, A. (1999). Identification and Rapid Quantification of Early- and Late-Lytic Human Herpesvirus 8 Infection in Single Cells by Flow Cytometric Analysis: Characterization of Antiherpesvirus Agents. J. Virol. 73: 5894-5902 [Abstract] [Full Text]  
  • Cannon, J. S., Hamzeh, F., Moore, S., Nicholas, J., Ambinder, R. F. (1999). Human Herpesvirus 8-Encoded Thymidine Kinase and Phosphotransferase Homologues Confer Sensitivity to Ganciclovir. J. Virol. 73: 4786-4793 [Abstract] [Full Text]  
  • Neyts, J., Andrei, G., De Clercq, E. (1998). The Antiherpesvirus Activity of H2G [(R)-9-[4-Hydroxy-2-(Hydroxymethyl)Butyl]Guanine] Is Markedly Enhanced by the Novel Immunosuppressive Agent Mycophenolate Mofetil. Antimicrob. Agents Chemother. 42: 3285-3289 [Abstract] [Full Text]  
  • Neyts, J., Balzarini, J., Andrei, G., Chaoyong, Z., Snoeck, R., Zimmermann, A., Mertens, T., Karlsson, A., De Clercq, E. (1998). Intracellular Metabolism of the N7-Substituted Acyclic Nucleoside Analog 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a Potent Inhibitor of Herpesvirus Replication. Mol. Pharmacol. 53: 157-165 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»